On May 8, 2024, Maxpro Investment Co., Ltd, a Cayman Islands-based company, filed a Schedule 13G with the United States Securities and Exchange Commission (SEC), indicating a significant ownership stake in Apollomics Inc. Maxpro reported beneficial ownership of 10,507,040 Class A ordinary shares of Apollomics, which represents approximately 9.64% of the company's issued and outstanding Class A ordinary shares. This stake includes 10,124,645 Class A ordinary shares and an additional 382,395 shares issuable upon the exercise of warrants within 60 days from the filing date. The filing followed Apollomics' issuance of 19,166,666 Class A ordinary shares in a private placement to certain accredited investors. Maxpro's filing is a standard disclosure for entities holding more than 5% of a company's shares and does not indicate an intention to change or influence the control of Apollomics. The information was certified as true and correct by Yi Kuei Chen on May 20, 2024.

On May 8, 2024, Maxpro Investment Co., Ltd, a Cayman Islands-based company, filed a Schedule 13G with the United States Securities and Exchange Commission (SEC), indicating a significant ownership stake in Apollomics Inc. Maxpro reported beneficial ownership of 10,507,040 Class A ordinary shares of Apollomics, which represents approximately 9.64% of the company's issued and outstanding Class A ordinary shares. This stake includes 10,124,645 Class A ordinary shares and an additional 382,395 shares issuable upon the exercise of warrants within 60 days from the filing date. The filing followed Apollomics' issuance of 19,166,666 Class A ordinary shares in a private placement to certain accredited investors. Maxpro's filing is a standard disclosure for entities holding more than 5% of a company's shares and does not indicate an intention to change or influence the control of Apollomics. The information was certified as true and correct by Yi Kuei Chen on May 20, 2024.